The metabolic syndrome as a risk factor for colorectal cancer

Objective. To evaluate the prognostic significance of metabolic syndrome (MS) in the development of colorectal cancer (CRC) using various MS criteria in Novosibirsk population. Materials and Methods. The study was designed as nested «case-control». Baseline population cohort (93...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tatiana M. Nikitenko, Lilia V. Shcherbakova, Sofia K. Malyutina, Svetlana V. Mustafina, Eugene G. Verevkin, Yuliya I. Ragino, Vladimir E. Voytsitsky, Anna V. Pyatibratova, Oksana D. Rymar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrinology Research Centre 2017-09-01
Saila:Ожирение и метаболизм
Gaiak:
metabolic syndrome
colorectal cancer
the components of the metabolic syndrome
colon and rectum cancer
Sarrera elektronikoa:https://www.omet-endojournals.ru/jour/article/view/8178
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak